Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Clin Drug Investig. 2019 May;39(5):441–451. doi: 10.1007/s40261-019-00764-x

Table 2.

Subject baseline characteristics and demographics in Studies P008 and P038

Characteristic Study P008 Study P038
Ketoconazole study Diltiazem sub-study Rifampin sub-study
Subjects (N = 10) Male (n = 14) Female (n = 6) Total (N = 20) Male (n = 8) Female (n = 2) Total (N = 10)
Mean age, years (range) 33 (22–45) 42 (28–50) 32 (23–41) 39 (23–50) 39 (28–45) 29 (18–40) 37 (18–45)
Mean height, cm (range) 175 (161.0–185.0) 178 (166.0–193.0) 165 (151.0–174.0) 174 (151.0–193.0) 180 (171.0–188.0) 165 (157.0–172.0) 177 (157.0–188.0)
Mean weight, kg (range) 81.9 (64.0–100.0) 83.8 (74.1–94.4) 71.2 (52.6–82.7) 80.0 (52.6–94.4) 85.6 (63.2–105.2) 60.2 (59.7–60.6) 80.5 (59.7–105.2)
Race, n (%)
 White 5 (50.0) 3 (21.4) 2 (33.3) 5 (25.0) 0 (0.0) 0 (0.0) 0 (0.0)
 Black 4 (40.0) 10 (71.4) 4 (66.7) 14 (70.0) 8 (100.0) 2 (100.0) 10 (100.0)
 Native American 1 (10.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
 Hispanic 0 (0.0) 1 (7.1) 0 (0.0) 1 (5.0) 0 (0.0) 0 (0.0) 0 (0.0)